Aenor Pharmaceuticals
Aenor Pharmaceuticals is an Indian PCD pharma franchise company operating WHO GMP certified manufacturing facilities and distributing 150+ allopathic, Ayurvedic, and veterinary products through franchise partners across India.
- Company typePrivate
- Founded2020
- HeadquartersHaryana, India
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Aenor Pharmaceuticals does
Aenor Pharmaceuticals Private Limited is a Haryana, India-based pharmaceutical company founded in 2020 that operates a PCD (Propaganda Cum Distribution) pharma franchise model with WHO GMP certified manufacturing facilities. The company produces a broad portfolio of over 150 pharmaceutical products spanning allopathic formulations (tablets, capsules, syrups, injectables, dry syrups, pediatric drops, diabetic products, eye drops, dental care, derma range), Ayurvedic products (pain relief oils), and veterinary medicines through its Aenor Vetcare sub-brand. Manufacturing is conducted in WHO GMP, ISO 9001, and ISO 13485 certified facilities following standard pharmaceutical quality protocols.
The company generates revenue through four primary streams: PCD pharma franchise partnerships where associates pay for exclusive territorial monopoly rights to distribute products; third-party contract manufacturing for other pharmaceutical companies; direct B2B sales to pharmacies, hospitals, and clinics via the franchise network; and pharma exports to international markets. The go-to-market approach targets pharmaceutical entrepreneurs, medical representatives seeking business ownership, existing pharmacy owners looking to expand, and veterinary distributors. Franchise partners receive marketing support, product training, and promotional materials, with engagement handled through phone (+91 90417 19455), WhatsApp, and website inquiries.
The company claims PAN India coverage across all 28 states and 8 union territories with 1,000+ satisfied clients. It holds ISO 13485 and ISO 9001 certifications alongside WHO GMP compliance. There is a noted discrepancy between the 2020 founding date in firmographic data and marketing materials claiming over 10 years of experience, which may reflect founder prior experience or entity restructuring.
Aenor Pharmaceuticals firmographics
Firmographics- Name
- Aenor Pharmaceuticals
- Legal name
- Aenor Pharmaceuticals Private Limited
- Website
- https://aenorpharma.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Aenor Pharmaceuticals is an Indian PCD pharma franchise company operating WHO GMP certified manufacturing facilities and distributing 150+ allopathic, Ayurvedic, and veterinary products through franchise partners across India.
- Ownership category
- akta.pro rank
Aenor Pharmaceuticals industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industries
- Generic Hospital & Institutional Products (HLAIABAL), Specialty Care Pharmaceuticals (HLAIAAAB), Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)
Keywords
Where Aenor Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Haryana
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Aenor Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- PCD Pharma Franchise: Revenue generated through franchise partnerships where associates pay for exclusive rights to market and distribute pharmaceutical products in specific territories. Franchise partners receive products at competitive prices and earn margins on sales.
- Third Party Manufacturing: Contract manufacturing services for other pharmaceutical companies requiring production capabilities. The company manufactures products for third parties using their WHO GMP certified facilities.
- Product Sales through Franchise Network: Direct sales of pharmaceutical products to healthcare providers, pharmacies, hospitals, and clinics through the established franchise distribution network across India.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Franchise partnership with monopoly rights - custom pricing based on territory and product selection |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Aenor Pharmaceuticals product offering
Product offeringCore offering
Aenor Pharmaceuticals manufactures and supplies a portfolio of 150+ allopathic, Ayurvedic, and veterinary pharmaceutical products (tablets, capsules, syrups, injectables, dry syrups, ointments, eye drops, paediatric drops, derma and nutraceutical formulations). It sells these products through a PCD (Propaganda Cum Distribution) franchise model that grants partners exclusive monopoly rights in defined Indian territories, alongside third-party/contract manufacturing services for other pharma companies and international pharmaceutical exports.
Product overview
Aenor Pharmaceuticals is a PCD (Propaganda Cum Distribution) pharma company in India offering a diverse portfolio of pharmaceutical products across multiple therapeutic categories. The company operates through two main divisions: the general pharmaceutical division handling allopathic products (tablets, capsules, syrups, injectables, dry syrups, eye drops, dental care, and pediatric formulations) and Aenor Vetcare for veterinary products. The product portfolio includes branded formulations like ACLOZIT-MR (pain relief tablets), ACLOZIT-P (syrup), AMIFAB-500 (antibiotic injection), AENOR Pain Oil (Ayurvedic pain relief), and DAYPLEX-L (nutritional supplement). The company provides franchise opportunities with monopoly rights, third-party manufacturing services using WHO GMP certified facilities, and export services. With over 150+ unique pharmaceutical products, Aenor serves healthcare needs across India through its PCD franchise network.
Differentiator
Problem solved
Functional benefit
Brands
- Aenor Vetcare: Veterinary pharmaceutical division of Aenor Pharmaceuticals focusing on animal healthcare products including antibiotics, feed supplements, vaccines, and nutritional care for livestock and pets.
Products and services
- PCD Pharma Franchise PCD (Propaganda Cum Distribution) franchise partnership granting exclusive monopoly rights to market and distribute Aenor's pharmaceutical products in a defined Indian territory, with marketing support, product training, and promotional materials provided.
- Third Party Manufacturing Contract manufacturing service for pharmaceutical companies requiring WHO GMP certified production capacity for their own branded formulations across multiple dosage forms.
- Derma PCD Franchise Specialized PCD franchise opportunity focused on dermatological and cosmetic pharmaceutical products (lotions, shampoos, soaps, facewash, creams, ointments).
- Veterinary PCD Pharma Franchise PCD franchise opportunity for veterinary pharmaceutical products (antibiotics, feed supplements, vaccines, calcium suspension, mineral mixture, liver tonic) for distribution to veterinary clinics and livestock farmers.
- Veterinary Third Party Manufacturing Contract manufacturing service for veterinary pharmaceutical formulations (antibiotics, feed supplements, vaccines, nutritional products) using Aenor's certified facilities.
- Pharma Export International pharmaceutical export service delivering Aenor's branded formulations to global healthcare markets.
Quantifiable outcome
- Over 1000 satisfied clients across India
- +3 more outcomes
Companies that use Aenor Pharmaceuticals
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
Aenor Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Aenor Pharmaceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Logistic Partners (Unnamed)minorThe company partners with logistics providers for transportation and delivery of pharmaceutical products across India, though specific partner names are not disclosed on their website.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Aenor Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Zuventus Healthcare: Zuventus (part of the Emami group) operates a PCD franchise and contract manufacturing business in India with comparable breadth across general pharma and derma, directly mirroring Aenor's franchise-led GTM.
- Ajanta Pharma: Ajanta operates a large-scale franchise and specialty pharma distribution network in India with comparable therapeutic breadth, including dermatology and pediatric segments that overlap with Aenor's portfolio.
- Aristo Pharmaceuticals: Aristo runs a comparable Indian PCD franchise program with a broad allopathic portfolio spanning tablets, capsules, injectables, and syrups, and competes head-to-head with Aenor for the same franchise-partner pool.
- Centaur Pharmaceuticals: Centaur is a mid-sized Indian pharma manufacturer that runs PCD franchise operations and third-party manufacturing, serving as a closer analog to Aenor in scale and franchise-led distribution model.
- Macleods Pharmaceuticals: Macleods is a leading Indian pharma manufacturer that operates an aggressive PCD franchise and contract manufacturing program across allopathic generics, dermatology, and critical care segments, directly competing with Aenor's franchise model and product breadth.
Broad incumbents
- Sun Pharmaceutical Industries: Sun Pharma is India's largest pharma company with extensive generic and specialty manufacturing, competing with Aenor at the manufacturing and distribution level across overlapping therapeutic categories.
- Cipla: Cipla is a top-tier Indian pharma manufacturer with a broad therapeutic portfolio and established distribution, representing a larger competitive force in the same category Aenor serves through franchise partners.
- Alkem Laboratories: Alkem is a top-10 Indian pharma manufacturer with broad generic, dermatology, and veterinary portfolios, comparable therapeutic breadth to Aenor, and a much larger established distribution franchise base.
- Lupin Limited: Lupin is a major Indian generic pharma manufacturer with a broad portfolio across tablets, injectables, and dermatology, comparable to Aenor's manufacturing and franchise distribution approach at significantly greater scale.
- Mankind Pharma: Mankind is one of India's largest pharma companies and runs an extensive PCD franchise network and broad allopathic portfolio, representing a scaled incumbent against which Aenor competes for franchise partners and shelf space.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Aenor Pharmaceuticals social profiles
Digital presenceAenor Pharmaceuticals compliance and trust
Trust signalCompliance3 records
Aenor Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aenor Pharmaceuticals leadership team
Management profileNumber of profiles
Aenor Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aenor Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aenor Pharmaceuticals
What does Aenor Pharmaceuticals do?
Aenor Pharmaceuticals manufactures and supplies a portfolio of 150+ allopathic, Ayurvedic, and veterinary pharmaceutical products (tablets, capsules, syrups, injectables, dry syrups, ointments, eye drops, paediatric drops, derma and nutraceutical formulations). It sells these products through a PCD (Propaganda Cum Distribution) franchise model that grants partners exclusive monopoly rights in defined Indian territories, alongside third-party/contract manufacturing services for other pharma companies and international pharmaceutical exports.
Is Aenor Pharmaceuticals a public or private company?
Aenor Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Aenor Pharmaceuticals founded?
Aenor Pharmaceuticals was founded in 2020. It employs 11 to 50 people.
Where is Aenor Pharmaceuticals based?
Aenor Pharmaceuticals is headquartered in Haryana, India, in the Asia region.
How does Aenor Pharmaceuticals make money?
Three revenue lines are on record. PCD Pharma Franchise is the primary driver. The others are third Party Manufacturing and product Sales through Franchise Network.
Who are Aenor Pharmaceuticals's main competitors?
Direct peers on record are Zuventus Healthcare, Ajanta Pharma, Aristo Pharmaceuticals, Centaur Pharmaceuticals and Macleods Pharmaceuticals. Broad incumbents are Sun Pharmaceutical Industries, Cipla, Alkem Laboratories, Lupin Limited and Mankind Pharma.
Does Aenor Pharmaceuticals have an API?
No public API is recorded for Aenor Pharmaceuticals.
What industry is Aenor Pharmaceuticals in?
Aenor Pharmaceuticals's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 42421 and its SIC code is 5122.